Is Carboplatin and Oral Etoposide an Effective and Feasible Regimen in Patients with Small Cell Lung Cancer?

By Pfeiffer P.   Sorensen P.   Rose C.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 64-69

Elsevier

Access to resources Recommend Favorite

Carboplatin-oral etoposide personalised dosing in elderly non-small cell lung cancer patients

By Frasci G.   Comella P.   Panza N.   De Cataldis G.   Del Gaizo F.   Pozzo C.   Gravina A.   Ruffolo P.   Cioffi R.   Marcatili P.   Della Vittoria M.   Monfardini S.   Comella G.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1710-1714

Elsevier

Access to resources Recommend Favorite

Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer

By Baandrup Louise   Hauggaard Anders   Winberg Birgitte H.   Holm Bente  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 465-467

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Trial Defining the Maximum Tolerated Systemic Exposure of Topotecan in Combination with Carboplatin and Etoposide in Extensive Stage Small Cell Lung Cancer

By Gillenwater Heidi   McCune Jeannine   Lindley Celeste   Faucette Stephanie   Shord Stacy   Donahue Angela   Socinski Mark   Stewart Clinton   Zamboni William   Kirstein Mark   Moore Dominic  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 511-519

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine, Ifosfamide and Cisplatin in Advanced Non-Small Cell Lung Cancer

By Tan Eng-Huat   Ang Peng Tiam   Wee Joseph   Fong Kam Weng   Leong Swan Swan   Khoo Kei Siong  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite